United States Sees Spate Of Intellectual Property Policy Activity 07/04/2010 by Kaitlin Mara for Intellectual Property Watch 2 Comments In the aftermath of the recent protracted fights over healthcare, the United States has seen a wave of intellectual property-related policy activity
UN Claims Victory In Biodiversity Talks, But Outcome Not Certain 06/04/2010 by Kaitlin Mara for Intellectual Property Watch 1 Comment The UN Convention on Biological Diversity last month hailed Cali, Colombia as the birthplace of a protocol they hope will lead to an international regime on access and benefit-sharing by their October 2010 deadline. But, while it is clear the late March negotiation in Cali brought significant progress, participants reported difficult disagreements and in the final days, signs that there is yet more work to be done.
Risk Of Wrongful Medicines Seizures Seen In EU-Central America Trade Deal 06/04/2010 by David Cronin for Intellectual Property Watch 1 Comment A new accord designed to bolster political and economic ties between the European Union and Central America could result in greater seizures of medicines whenever pharmaceutical companies allege that their patents have been infringed, public health advocates have warned.
March/April Edition Of IP-Watch Monthly Reporter Now Available 31/03/2010 by Intellectual Property Watch, Intellectual Property Watch 1 Comment The Intellectual Property Watch Monthly Edition features top news on international IP policymaking, the latest on who is coming and going in the international IP community, news briefs and more. The March/April edition is now available for subscribers at: http://www.ip-watch.org/user/newsletter.
Proponents Seek To Develop Policy Potential Of US Geographical Indications 31/03/2010 by Catherine Saez, Intellectual Property Watch Leave a Comment Advocates of stronger protection of geographical indications are working to develop greater awareness in Geneva policy circles, trying to win over countries reluctant to adopt a specific GI protection system.
British Official To Lead UPOV As Civil Society Interest Rises 28/03/2010 by Kaitlin Mara for Intellectual Property Watch Leave a Comment The International Union for the Protection of New Varieties of Plants (UPOV), an intergovernmental agency that provides technical advice and guidelines for the identification and protection of new plants, will have a new leader for the first time in a decade, it was decided Friday.
EU To Request Publication Of ACTA Documents To Stop “Rumours”; Civil Society Meeting Planned 22/03/2010 by Monika Ermert for Intellectual Property Watch Leave a Comment Europe will request the publication of the current drafts for the Anti-Counterfeiting Trade Agreement (ACTA) at the next ACTA negotiating meeting in New Zealand in April, EU trade official Luc Devigne said today. Speaking at the third EU stakeholder meeting on the hotly debated ACTA today in Brussels, Devigne also said there is also a meeting with civil society planned to take place alongside the New Zealand round.
The US-Cotton Case — The Truth Behind Brazil’s Cross-Retaliation Against US Intellectual Property 18/03/2010 by Intellectual Property Watch 9 Comments In a recent speech at the Export-Import Bank’s annual conference, US President Obama said the US Trade Representative will use its “full arsenal” to combat “practices that blatantly harm” US businesses, and that includes “enforcing existing [US] agreements.” The question is: will the US comply with its multilateral obligations under the WTO agreement in the US-Brazil cotton case, says Brazilian academic Pedro Paranaguá.
Public Health Policy In 2010: Research Funding And Regulations 17/03/2010 by Kaitlin Mara for Intellectual Property Watch 1 Comment Finding ways to fund research and regulating medication is critical to international public health policy and intellectual property rights specialists in 2010.
AIDS Patients Protest EU-India Trade Agreement 12/03/2010 by Intellectual Property Watch 3 Comments Patients with HIV/AIDS today protested in New Delhi against negotiations for a European Union-India free trade agreement that they say will restrict access to cheaper versions of critical medicines in developing countries. Médecins Sans Frontières (MSF, or Doctors without Borders) said in a statement that India is the source of more than 90 percent of […]